232 related articles for article (PubMed ID: 18097662)
1. Metastatic myxoid liposarcomas: imaging and histopathologic findings.
Sheah K; Ouellette HA; Torriani M; Nielsen GP; Kattapuram S; Bredella MA
Skeletal Radiol; 2008 Mar; 37(3):251-8. PubMed ID: 18097662
[TBL] [Abstract][Full Text] [Related]
2. Whole-body magnetic resonance imaging in myxoid liposarcoma: A useful adjunct for the detection of extra-pulmonary metastatic disease.
Stevenson JD; Watson JJ; Cool P; Cribb GL; Jenkins JP; Leahy M; Gregory JJ
Eur J Surg Oncol; 2016 Apr; 42(4):574-80. PubMed ID: 26831007
[TBL] [Abstract][Full Text] [Related]
3. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic efficacy of bone scintigraphy, magnetic resonance imaging, and positron emission tomography in bone metastases of myxoid liposarcoma.
Conill C; Setoain X; Colomo L; Palacín A; Combalia-Aleu A; Pomés J; Marruecos J; Vargas M; Maurel J
J Magn Reson Imaging; 2008 Mar; 27(3):625-8. PubMed ID: 18307201
[TBL] [Abstract][Full Text] [Related]
5. Early detection of multiple bone and extra-skeletal metastases by body magnetic resonance imaging (BMRI) after treatment of Myxoid/Round-Cell Liposarcoma (MRCLS).
Gouin F; Renault A; Bertrand-Vasseur A; Bouilleau L; Crenn V; Rosset P; Tallegas M; Samargandi R; Le Nail LR
Eur J Surg Oncol; 2019 Dec; 45(12):2431-2436. PubMed ID: 31447287
[TBL] [Abstract][Full Text] [Related]
6. Round cell liposarcoma arising in the left foot: MRI and PET findings.
Kudo H; Inaoka T; Tokuyama W; Hiruta N; Nakagawa K; Hayashi A; Terada H
Jpn J Radiol; 2012 Dec; 30(10):852-7. PubMed ID: 22965582
[TBL] [Abstract][Full Text] [Related]
7. Fluorinated deoxyglucose positron emission tomography imaging in progressive metastatic prostate cancer.
Morris MJ; Akhurst T; Osman I; Nunez R; Macapinlac H; Siedlecki K; Verbel D; Schwartz L; Larson SM; Scher HI
Urology; 2002 Jun; 59(6):913-8. PubMed ID: 12031380
[TBL] [Abstract][Full Text] [Related]
8. Metastatic patterns of extremity myxoid liposarcoma and their outcome.
Estourgie SH; Nielsen GP; Ott MJ
J Surg Oncol; 2002 Jun; 80(2):89-93. PubMed ID: 12173385
[TBL] [Abstract][Full Text] [Related]
9. Spinal metastases from myxoid liposarcoma warrant screening with magnetic resonance imaging.
Schwab JH; Boland PJ; Antonescu C; Bilsky MH; Healey JH
Cancer; 2007 Oct; 110(8):1815-22. PubMed ID: 17724681
[TBL] [Abstract][Full Text] [Related]
10. FDG PET/CT findings in rare sarcomas.
Ergül N; Aydın M
Rev Esp Med Nucl Imagen Mol; 2013; 32(5):324-7. PubMed ID: 23352751
[TBL] [Abstract][Full Text] [Related]
11. Combined 18F-FDG and 11C-methionine PET scans in patients with newly progressive metastatic prostate cancer.
Nuñez R; Macapinlac HA; Yeung HW; Akhurst T; Cai S; Osman I; Gonen M; Riedel E; Scher HI; Larson SM
J Nucl Med; 2002 Jan; 43(1):46-55. PubMed ID: 11801702
[TBL] [Abstract][Full Text] [Related]
12.
Lunn BW; Littrell LA; Wenger DE; Broski SM
Skeletal Radiol; 2018 Dec; 47(12):1641-1650. PubMed ID: 29926115
[TBL] [Abstract][Full Text] [Related]
13. Metastatic prostate cancer: initial findings of PET with 2-deoxy-2-[F-18]fluoro-D-glucose.
Shreve PD; Grossman HB; Gross MD; Wahl RL
Radiology; 1996 Jun; 199(3):751-6. PubMed ID: 8638000
[TBL] [Abstract][Full Text] [Related]
14. Appearance of untreated bone metastases from breast cancer on FDG PET/CT: importance of histologic subtype.
Dashevsky BZ; Goldman DA; Parsons M; Gönen M; Corben AD; Jochelson MS; Hudis CA; Morrow M; Ulaner GA
Eur J Nucl Med Mol Imaging; 2015 Oct; 42(11):1666-1673. PubMed ID: 25971426
[TBL] [Abstract][Full Text] [Related]
15. Osseous metastases of chordoma: imaging and clinical findings.
Chang C; Chebib I; Torriani M; Bredella M
Skeletal Radiol; 2017 Mar; 46(3):351-358. PubMed ID: 28064345
[TBL] [Abstract][Full Text] [Related]
16. The impact of
Elmanzalawy A; Vali R; Chavhan GB; Gupta AA; Omarkhail Y; Amirabadi A; Shammas A
Pediatr Radiol; 2020 Feb; 50(2):252-260. PubMed ID: 31628508
[TBL] [Abstract][Full Text] [Related]
17. Staging and Surveillance of Myxoid Liposarcoma: Follow-up Assessment and the Metastatic Pattern of 169 Patients Suggests Inadequacy of Current Practice Standards.
Visgauss JD; Wilson DA; Perrin DL; Colglazier R; French R; Mattei JC; Griffin AM; Wunder JS; Ferguson PC
Ann Surg Oncol; 2021 Nov; 28(12):7903-7911. PubMed ID: 33961173
[TBL] [Abstract][Full Text] [Related]
18. Prevalence and patterns of bone metastases detected with positron emission tomography using F-18 FDG.
Nakamoto Y; Osman M; Wahl RL
Clin Nucl Med; 2003 Apr; 28(4):302-7. PubMed ID: 12642709
[TBL] [Abstract][Full Text] [Related]
19. Soft tissue liposarcoma: histological subtypes, MRI and CT findings.
Barile A; Zugaro L; Catalucci A; Caulo M; Di Cesare E; Splendiani A; Gallucci M; Masciocchi C
Radiol Med; 2002 Sep; 104(3):140-9. PubMed ID: 12471362
[TBL] [Abstract][Full Text] [Related]
20. [Contribution of whole-body MRI to the initial assessment of myxoid liposarcoma].
Dewaguet J; Beaujot J; Leguillette C; Decanter G; Cordoba A; Penel N; Ceugnart L; Taieb S; Amor MBH
Bull Cancer; 2023 Oct; 110(10):1015-1026. PubMed ID: 37507239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]